Abeona Therapeutics Inc.
ABEO
$5.29
$0.428.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 400.00K | 400.00K | -- | -- | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 400.00K | 400.00K | -- | -- | 0.00 |
| Cost of Revenue | 29.68M | 33.92M | 37.09M | 34.36M | 32.75M |
| Gross Profit | -29.28M | -33.52M | -37.09M | -34.36M | -32.75M |
| SG&A Expenses | 53.93M | 41.02M | 32.51M | 29.85M | 28.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 83.61M | 74.94M | 69.61M | 64.21M | 60.75M |
| Operating Income | -83.21M | -74.54M | -69.61M | -64.21M | -60.75M |
| Income Before Tax | 82.67M | 72.75M | -44.19M | -63.73M | -71.03M |
| Income Tax Expenses | 315.00K | 15.51M | -- | -- | -- |
| Earnings from Continuing Operations | 82.35 | 57.24 | -44.19 | -63.73 | -71.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 82.35M | 57.24M | -44.19M | -63.73M | -71.03M |
| EBIT | -83.21M | -74.54M | -69.61M | -64.21M | -60.75M |
| EBITDA | -80.98M | -72.43M | -67.56M | -62.21M | -58.79M |
| EPS Basic | 1.54 | 1.01 | -0.88 | -1.79 | -2.25 |
| Normalized Basic EPS | -0.84 | -1.00 | -0.55 | -1.12 | -1.40 |
| EPS Diluted | 1.17 | 0.64 | -1.33 | -2.24 | -2.69 |
| Normalized Diluted EPS | -0.77 | -0.93 | -0.57 | -1.14 | -1.43 |
| Average Basic Shares Outstanding | 205.23M | 199.07M | 186.55M | 164.09M | 141.10M |
| Average Diluted Shares Outstanding | 219.34M | 213.18M | 197.77M | 175.30M | 152.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |